GGrantIndex
Sort

8,912 grants matching sars cov 2

High-throughput Imaging-integrated Vascular Model for Understanding Thromboembolism and Therapeutics Screening

$618,421
Y. Shrike Zhang · Brigham And Women'S Hospital · R01 · FY2025 · HL

Uganda International Center for Excellence in Research

$618,078
Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Macaque Model and Gene Expression Profiling of SARS

$618,070
Michael G Katze · University Of Washington · R01 · FY2007 · HL

Exploring the thymic origin of group 2 innate lymphoid cells

$618,011
Xiao-Hong Sun · Oklahoma Medical Research Foundation · R56 · FY2021 · AI

Overriding the Immune Evasion Tactics of Coronavirus

$617,996
Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AI

Overriding the Immune Evasion Tactics of Coronavirus

$617,996
Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AI

Role and Mitigation of Inflammasomes and Inflammation During COVID-19

$617,741
Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI

Synthetic RNA Switch-Based Temporal and Dose Control of in Vivo Gene Therapies

$617,738
Guocai Zhong · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · EB

Longitudinal study of health outcomes and mitigating factors in the aftermath of the COVID pandemic

$617,720
Manoj Mohanan · Duke University · R01 · FY2025 · HD

Behavioral and Social Science Research to Optimize SARS-CoV-2 Protective Vaccine Uptake in Racial Minority Communities with High Rates of COVID-19

$617,614
Jeffrey A. Kelly · Medical College Of Wisconsin · R01 · FY2022 · MD

Predicting Post-Covid Pulmonary Fibrosis with Explainable Deep Learning and Optimal Biomarker Discovery

$617,578
Ulas Bagci · Northwestern University At Chicago · R01 · FY2025 · HL

Project 1: Durable impact of COVID on innate and adaptive immunity

$616,990
Michela Locci · Massachusetts General Hospital · U19 · FY2024 · AI

Coronavirus Challenge Core

$616,900
Matthew Bryan Frieman · Washington University · P01 · FY2025 · AI

Kmt2a/MLL1 regulation of endothelial activation

$616,880
Andrea Tara Obi · University Of Michigan At Ann Arbor · R01 · FY2025 · HL

Targeting SARS-CoV-2 PLpro for COVID-19 treatment

$616,612
Rui Xiong · University Of Arizona · R01 · FY2025 · AI

Mitochondrial metabolism controls alveolar epithelial cell fate

$616,000
Seunghye Han · Northwestern University At Chicago · R01 · FY2024 · HL

Small GTP Binding Proteins in Gastrointestinal Mucosa

$615,274
James R Goldenring · Vanderbilt University Medical Center · R01 · FY2022 · DK

Small GTP Binding Proteins in Gastrointestinal Mucosa

$615,274
James R Goldenring · Vanderbilt University Medical Center · R01 · FY2023 · DK

Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy

$615,261
Gulin Oz · University Of Minnesota · R01 · FY2024 · NS

Isolation of bioactive proteins from natural product extracts

$615,101
Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Elucidating the roles of alveolar macrophage inflammation and self renewal during influenza infection

$614,905
Jie Sun · University Of Virginia · R01 · FY2025 · AG

Vanderbilt Vaccine and Treatment Evaluation Unit

$614,901
Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2021 · AI

Mobile Health for Migrant Health (mHealth-4-Mhealth): Assessing the Effectiveness of Implementing an mHealth Program to Increase COVID-19 Testing and Treatment Among Rural Migrant Families

$614,873
Russell James McCulloh · University Of Nebraska Medical Center · R01 · FY2024 · MD

Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization

$614,795
Yi Shi · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI

Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases

$614,732
Maria Ioana Danila · University Of Alabama At Birmingham · R01 · FY2025 · MD